NCT00670553 2017-05-17A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck CancerNovartisPhase 1 Completed7 enrolled